According to a recent LinkedIn post from Latent, Cone Health’s Chief Pharmacy Officer Kristen Kruszewski is being highlighted for work on more centralized and scalable medication access models. The post describes efforts to improve visibility, standardize workflows, and expand team capacity, with the goal of accelerating patient care delivery.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
As described in the post, Cone Health has reportedly expanded centralized coverage from 65 to more than 80 of its highest-prescription-volume clinics while operating with four fewer FTEs. The post also notes increases in central pharmacy prior-authorization volume and reductions in turnaround time, implying gains in operational efficiency.
The LinkedIn content suggests that Latent is positioning its platform and expertise around measurable, centralized pharmacy processes that support large health systems. For investors, this emphasis may indicate a focus on value propositions such as cost efficiency, workforce optimization, and faster medication access, which could be attractive in a margin-constrained provider environment.
The post also points to Kristen Kruszewski’s participation at a Becker’s Healthcare pharmacy leadership event, where future demands on pharmacy infrastructure will be discussed. Visibility at such industry forums could enhance Latent’s brand recognition among health system executives and potentially support future business development and partnership opportunities.